Ledger.Open graph →
SEC Form D · Amendment · filed May 11, 2017

Vivex Biomedical, Inc

Offering
$7.0M
Sold
$6.3M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
ATLANTA, GA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (34)

Tracy S. Anderson · Atlanta, GAExec · DirectorJ. M. Fernandez De Castro · Atlanta, GADirectorDr. H T. Temple · Atlanta, GAExecTimothy T. Ganey, Ph.D · Atlanta, GAExecU. B. Ellis, Jr · Atlanta, GADirectorRichard E. Perlman · Atlanta, GADirectorHolly S. Mason · Atlanta, GAExecTimothy S. Taylor · Atlanta, GADirectorJames K. Price · Atlanta, GADirectorBarry T. Salzman · Atlanta, GADirectorJohn A. Mccallum · Atlanta, GADirectorMary Ann M. Sigler · Beverly Hills, CAExecRonald M. Mateo · NEW YORK, NYDirectorMatthew M. Danzeisen · NEW YORK, NYDirectorChristian M. Lange · NEW YORK, NYExecDerek L. Ross · Boston, MADirectorPaul Lee · San Francisco, CADirectorDaniel M. Siracuse · New York, NYExecPhilip M. Desantis · New York, NYDirectorMichael M. Sobel · NEW YORK, NYExec · DirectorJim Kim · San Francisco, CADirectorStuart J. Komenski · Atlanta, GAExecPeter L. Slavin · Boston, MADirectorStanley L. Morten · Boston, MAExecBrendan F. O'Grady · Boston, MAExecNazim L. Cetin · Boston, MADirectorBradford F. Gay · Boston, MADirectorIdo Schoenberg · Boston, MAExec · DirectorDeval F. Patrick · Boston, MADirectorJohn F. Jesser · Boston, MADirectorRoy Schoenberg · Boston, MAExecGeoffrey T. Gentile · New York, NYDirectorColin T. Moran · New York, NYDirectorStuart J. Komenski · Atlanta, GAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗